Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology

Controlled Trials ◽

Phase 2 ◽

Phase 3 ◽

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Psychopharmacology ◽

10.1007/s00213-019-05249-5 ◽

2019 ◽

Vol 236 (9) ◽

pp. 2735-2745 ◽

Cited By ~ 40

Author(s):

Michael C. Mithoefer ◽

Allison A. Feduccia ◽

Lisa Jerome ◽

Anne Mithoefer ◽

Mark Wagner ◽

...

Keyword(s):

Study Design ◽

Pooled Analysis ◽

Controlled Trials ◽

Phase 2 ◽

Phase 3 ◽

Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.07.002 ◽

2019 ◽

Vol 80 (1) ◽

pp. 128-138.e2 ◽

Cited By ~ 20

Author(s):

Dee Anna Glaser ◽

Adelaide A. Hebert ◽

Alexander Nast ◽

William P. Werschler ◽

Lawrence Green ◽

...

Keyword(s):

Controlled Trials ◽

Axillary Hyperhidrosis ◽

Phase 3 ◽

Rationale and design of two, phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory and unexplained chronic cough

World Allergy Organization Journal ◽

10.1016/j.waojou.2020.100203 ◽

2020 ◽

Vol 13 (8) ◽

pp. 100203

Author(s):

David Muccino ◽

George Philip ◽

A.H. Morice ◽

S.S. Birring ◽

L. Mcgarvey ◽

...

Keyword(s):

Receptor Antagonist ◽

Chronic Cough ◽

Controlled Trials ◽

P2x3 Receptor ◽

Phase 3 ◽

Two Phase ◽

Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials

Diabetes Therapy ◽

10.1007/s13300-020-00803-3 ◽

2020 ◽

Vol 11 (6) ◽

pp. 1347-1367 ◽

Cited By ~ 3

Author(s):

Shrita Patel ◽

Anne Hickman ◽

Robert Frederich ◽

Susan Johnson ◽

Susan Huyck ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Pooled Analysis ◽

Controlled Trials ◽

Phase 3 ◽

Safety and tolerability of cancer drugs studied in phase 3 randomized controlled trials (RCTs) over the last decade.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.6588 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 6588-6588

Author(s):

Domen Ribnikar ◽

Hadar Goldvaser ◽

Alberto Ocana ◽

Arnoud J. Templeton ◽

Bostjan Seruga ◽

...

Keyword(s):

Controlled Trials ◽

Cancer Drugs ◽

Phase 3 ◽

Risk of hematological and gastrointestinal toxicities in patients with advanced neuroendocrine tumors treated with everolimus: A meta-analysis of phase 3 randomized controlled trials.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e16184 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e16184-e16184

Author(s):

Anita Sultan ◽

Kyaw Zin Thein ◽

Sriman Swarup ◽

Somedeb Ball ◽

Lukman Aderoju Tijani ◽

...

Keyword(s):

Neuroendocrine Tumors ◽

Meta Analysis ◽

Controlled Trials ◽

Phase 3 ◽

Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.03.040 ◽

2018 ◽

Vol 79 (2) ◽

pp. 287-293 ◽

Cited By ~ 15

Author(s):

Linda Stein Gold ◽

Mark G. Lebwohl ◽

Jeffrey L. Sugarman ◽

David M. Pariser ◽

Tina Lin ◽

...

Keyword(s):

Plaque Psoriasis ◽

Fixed Combination ◽

Controlled Trials ◽

Phase 3 ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis ◽

Improvement in itch and other psoriasis symptoms with brodalumab in phase 3 randomized controlled trials

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.14913 ◽

2018 ◽

Vol 32 (8) ◽

pp. 1305-1313 ◽

Cited By ~ 8

Author(s):

A.B. Gottlieb ◽

K. Gordon ◽

S. Hsu ◽

B. Elewski ◽

L.F. Eichenfield ◽

...

Keyword(s):

Controlled Trials ◽

Phase 3 ◽

Evaluation of co-morbid conditions among refractory or unexplained chronic cough patients in two phase 2 randomized controlled trials

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2019.12.228 ◽

2020 ◽

Vol 145 (2) ◽

pp. AB209

Author(s):

Mandel Sher ◽

Surinder Birring ◽

Alyn Morice ◽

Lorcan McGarvey ◽

Jacky Smith ◽

...

Keyword(s):

Chronic Cough ◽

Controlled Trials ◽

Phase 2 ◽

Two Phase ◽

Randomized Controlled ◽

Morbid Conditions

Risk of hematological toxicities in patients with advanced breast cancer treated with everolimus: A meta-analysis of phase 3 randomized controlled trials.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e13087 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e13087-e13087

Author(s):

Anita Sultan ◽

Kyaw Zin Thein ◽

Sriman Swarup ◽

Ruth D’Cunha ◽

Fred L. Hardwicke ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Meta Analysis ◽

Advanced Breast ◽

Controlled Trials ◽

Phase 3 ◽